Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy

Abstract

The AIT product and commercial vaccines containing the adjuvant MPLA were shown to modulate the induction of immune responses by changing the metabolic state of mDCs. Better understanding the mechanisms underlying the interactions between cell metabolism and immune responses will allow us to further improve vaccine development and AIT.